Atlas Trials

Safety of Batracylin in Patients With Solid Tumors and Lymphomas

Clinical trial NCT00450502 · COMPLETED

Trial details

NCT number
NCT00450502
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2007-02-24
Primary completion
2011-04-24
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.